TIMP1 Is a Prognostic Marker for the Progression and Metastasis of Colon Cancer Through FAK-PI3K/AKT and MAPK Pathway

Journal of Experimental and Clinical Cancer Research - United Kingdom
doi 10.1186/s13046-016-0427-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

miR-19b Serves as a Prognostic Biomarker of Breast Cancer and Promotes Tumor Progression Through PI3K/AKT Signaling Pathway

OncoTargets and Therapy
OncologyPharmacology
2018English

Conformation-Dependent Binding of a Tetrastatin Peptide to Αvβ3 Integrin Decreases Melanoma Progression Through FAK/PI3K/Akt Pathway Inhibition

Scientific Reports
Multidisciplinary
2018English

ZNF692 Promotes Colon Adenocarcinoma Cell Growth and Metastasis by Activating the PI3K/AKT Pathway

International Journal of Oncology
Cancer ResearchOncology
2019English

LIFR Is a Breast Cancer Metastasis Suppressor Upstream of the Hippo-Yap Pathway and a Prognostic Marker

Nature Medicine
BiochemistryMedicineGeneticsMolecular Biology
2012English

TrkB Promotes Laryngeal Cancer Metastasis via Activation PI3K/AKT Pathway

Oncotarget
Oncology
2017English

PSMA Redirects MAPK to PI3K-AKT Signaling to Promote Prostate Cancer Progression

Molecular and Cellular Oncology
Cancer ResearchMolecular Medicine
2017English

L1TD1 - A Prognostic Marker for Colon Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Corrigendum: DT-13 Inhibits Proliferation and Metastasis of Human Prostate Cancer Cells Through Blocking PI3K/Akt Pathway

Frontiers in Pharmacology
Pharmacology
2020English

Mir‑106a Regulates Cell Proliferation and Apoptosis of Colon Cancer Cells Through Targeting the PTEN/PI3K/AKT Signaling Pathway

Oncology Letters
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy